The global tissue diagnostics market size was valued at USD 19,907.1 million in 2021 and is poised to grow at a significant CAGR of 9.5% during the forecast period 2022-28. The factors that are boosting the growth of the tissue diagnostics market are increasing incidences of cancer, developing infrastructure for cancer diagnosis, availability of reimbursement policies, expanding healthcare expenditure, and recommendation of cancer screening. The pathology industry has started focusing on anatomic pathology due to industry fragmentation, high skilled nature of anatomic pathology services, and substantial historical growth in demand for anatomic pathology services despite payment cuts. This provides an opportunity for manufacturers of anatomic pathology solutions to invest in independent pathology laboratories because demand for pathology services.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-tissue-diagnostics-market/     

The tissue diagnostics market detailed segmentation:
1) By Product Type: Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology.
2) By Application: Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Other Cancers.
3) By End-User: Hospitals, Research Laboratories, Pharmaceutical Organizations, Contract Research Organizations (CROs).

Anatomic Pathology Segment Dominates the Tissue Diagnostics Market
The anatomic pathology segment is expected to contribute the highest revenue share of 75.4 percent in the tissue diagnostics market in 2020, owing to the increasing demand for anatomic pathology labs and advanced technologies. Furthermore, a growing number of hospitals are offering laboratory outreach programs, which is projected to propel the anatomic pathology market forward.

Request sample report at  https://precisionbusinessinsights.com/request-sample/?product_id=24463     

North America Leads Tissue Diagnostics Market
Due to easy access to modern technology, laboratory work, government initiatives, and increased healthcare expenditure, North America had the greatest revenue share in the global tissue diagnostics market in 2021, accounting for USD 10,376.3 Mn. Additionally, the increased frequency of cancer among the older population fueled the expansion of the tissue diagnostics market in North America. Asia Pacific is anticipated to grow with a 10.2% CAGR over the forecast period to reach USD 6,183.2 Mn.                                         
The tissue diagnostics market key players are Enzo Life Sciences, Agilent technologies, F. Hoffmann-La Roche Ltd, QIAGEN, Bio SB, Abbott., Merck KGaA, Darmstadt, Cell Signalling Technology, Inc., and Becton, Dickinson, and Company.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights^TM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747